^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

Meta10-19

i
Other names: Meta10-19, metabolically armed CD19 CAR-T, Meta1019, Meta 10-19
Associations
Company:
Leman Biotech
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations
7ms
New P1 trial • CAR T-Cell Therapy
|
cyclophosphamide • Meta10-19
1year
New P1 trial • CAR T-Cell Therapy
|
MYC (V-myc avian myelocytomatosis viral oncogene homolog) • BCL2 (B-cell CLL/lymphoma 2) • CD19 (CD19 Molecule) • BCL6 (B-cell CLL/lymphoma 6) • IL6 (Interleukin 6)
|
CD19 expression • BCL2 translocation
|
cyclophosphamide • Meta10-19
over1year
New P1 trial • CAR T-Cell Therapy
|
CD19 (CD19 Molecule)
|
CD19 expression
|
cyclophosphamide • Meta10-19
almost2years
Enrollment open • CAR T-Cell Therapy
|
CD19 (CD19 Molecule)
|
CD19 expression
|
cyclophosphamide • Meta10-19
almost2years
New P1 trial • CAR T-Cell Therapy
|
CD19 (CD19 Molecule)
|
CD19 expression
|
cyclophosphamide • Meta10-19